A Double Dose of Good News for Andrx
Andrx Corp. (ADRX ) says in a study, an approximate 6% additional lowering of LDL cholesterol was achieved with each doubled dosage of the company's Altocor drug. Merrill reiterates near, and long term buy.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.